Doha: As part of Hamad Medical Corporation’s (HMC) commitment to nurture and support the next generation of clinical leaders, three senior Qatari clinicians have completed the prestigious New and Emerging Academic Leaders (NEAL) programme at the University of Toronto’s Centre for Faculty Development.
The first group of the clinicians, supported by HMC’s Academic Health System Office, graduated from the highly competitive year-long programme in May.
They are: Dr. Noora Mohammed Al Hammadi, Chairman, Radiation Oncology, HMC, and Assistant Professor, Clinical Radiation Oncology, Weill Cornell Medical College-Qatar; Dr. Jassim Al Suwaidi, Executive Director, Cardiovascular Research, and Senior Consultant, Interventional Cardiologist, HMC; and Dr. Abdulla Al Ansari, Deputy Chief Medical Officer, Surgical Services, HMC. The intensive course involved three five-day trips to the campus in Canada and assignments and webinars while they were back in Doha.
NEAL focuses on building skills and expertise in important domains that underpin academic leadership — intrapersonal; interpersonal; organisational; and system.
Equipping clinical leaders with these skills allows them to think more broadly and helps them successfully lead their clinical areas and research and academic programme and help their colleagues to be successful.
Professor Bill McKenna, Institutional Officer for Research, HMC, said an important pillar of the corporation’s Academic Health System is to develop the next generation of clinical, academic and research leaders.
“This means providing development opportunities for existing leaders and senior colleagues, helping them understand their leadership roles within an academic health context, and enabling them to become ambassadors for change in the system and support the development of new or novice colleagues, who will assume these leadership roles in the future,” he said.
“The programme attracts some of the best and brightest clinicians from around the globe. It is an ideal opportunity to share best practices and experiences that will bring real results for our patients and the community.”
Dr. Al Hammadi said the programme was of great benefit to her and her colleagues. “It was a unique opportunity to work with experienced academic leaders from many different institutions and at different stages of their careers.
“The programme is unique as it focuses on building leadership abilities within an academic health context. We are all in a position to translate that learning and experience into real benefits for our patients,” she added. HMC will send three more clinical leaders for the next intake of the programme this September.
The Peninsula
Doha: As part of Hamad Medical Corporation’s (HMC) commitment to nurture and support the next generation of clinical leaders, three senior Qatari clinicians have completed the prestigious New and Emerging Academic Leaders (NEAL) programme at the University of Toronto’s Centre for Faculty Development.
The first group of the clinicians, supported by HMC’s Academic Health System Office, graduated from the highly competitive year-long programme in May.
They are: Dr. Noora Mohammed Al Hammadi, Chairman, Radiation Oncology, HMC, and Assistant Professor, Clinical Radiation Oncology, Weill Cornell Medical College-Qatar; Dr. Jassim Al Suwaidi, Executive Director, Cardiovascular Research, and Senior Consultant, Interventional Cardiologist, HMC; and Dr. Abdulla Al Ansari, Deputy Chief Medical Officer, Surgical Services, HMC. The intensive course involved three five-day trips to the campus in Canada and assignments and webinars while they were back in Doha.
NEAL focuses on building skills and expertise in important domains that underpin academic leadership — intrapersonal; interpersonal; organisational; and system.
Equipping clinical leaders with these skills allows them to think more broadly and helps them successfully lead their clinical areas and research and academic programme and help their colleagues to be successful.
Professor Bill McKenna, Institutional Officer for Research, HMC, said an important pillar of the corporation’s Academic Health System is to develop the next generation of clinical, academic and research leaders.
“This means providing development opportunities for existing leaders and senior colleagues, helping them understand their leadership roles within an academic health context, and enabling them to become ambassadors for change in the system and support the development of new or novice colleagues, who will assume these leadership roles in the future,” he said.
“The programme attracts some of the best and brightest clinicians from around the globe. It is an ideal opportunity to share best practices and experiences that will bring real results for our patients and the community.”
Dr. Al Hammadi said the programme was of great benefit to her and her colleagues. “It was a unique opportunity to work with experienced academic leaders from many different institutions and at different stages of their careers.
“The programme is unique as it focuses on building leadership abilities within an academic health context. We are all in a position to translate that learning and experience into real benefits for our patients,” she added. HMC will send three more clinical leaders for the next intake of the programme this September.
The Peninsula
